Geoff Meacham analyst BAML

Currently, out of the existing stock ratings of Geoff Meacham - 175 which are a Buy (51.02%), 136 which are a Hold (39.65%), 32 which are a Sell (9.33%)

Geoff Meacham

Work Performance Price Targets & Ratings Chart

Analyst Geoff Meacham works at BAML and is covering Healthcare, Technology sectors with 596 price targets and ratings displayed on 48 stocks. Previously, Geoff Meacham worked at BARCLAYS.

Geoff Meacham's average stock forecast success ratio is 67.7% with an average time for price targets to be met of 224.67 days.

Most recent stock forecast was given on GILD, Gilead Sciences at 08-Sep-2023.

Wall Street Analyst Geoff Meacham

Analyst best performing recommendations are on TYRA.
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 8/8/2018. The price target of $43 was fulfilled within 1 day with a profit of $2.28 (5.6%) receiving and performance score of 55.99.

Average potential price target upside

ALXN AMGN Amgen BIIB Biogen BMRN BioMarin Pharmaceutical BMY BristolMyers Squibb Company BTAI BioXcel Therapeutics CMPI CVAC CureVac N.V. GILD Gilead Sciences IIVI IIVI INCY yte INO Inovio Pharmaceuticals JNJ Johnson & Johnson LLY Eli Lilly and Company MRK Merck . MRNA Moderna PFE Pfizer REGN Regeneron Pharmaceuticals VRTX Vertex Pharmaceuticals KNSA Kiniksa Pharmaceuticals, Ltd PMVP PMV Pharmaceuticals PTCT PTC Therapeutics SGEN Seattle Genetics ABBV AbbVie ARAV Aravive CELG KYMR Kymera Therapeutics NBIX Neurocrine Biosciences ABOS UTHR United Therapeutics VAXX XLRN Acceleron Pharma ALNY Alnylam Pharmaceuticals ACHN BBIO BridgeBio Pharma CMRX Chimerix CRBU CRSP CRISPR Therapeutics AG GRPH ICPT Intercept Pharmaceuticals IPSC MYOV Myovant Sciences Ltd OMER Omeros PRTA RPRX RTRX TYRA IGMS IGM Biosciences

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$-9.5 (-5.21%)


2 years 5 months ago

14/24 (58.33%)

$55.25 (44.76%)




$-16.5 (-9.04%)


2 years 7 months 29 days ago

26/26 (100%)

$55.25 (49.07%)




2 years 8 months 26 days ago

7/7 (100%)

$42.28 (38.07%)




$-7.5 (-4.11%)


2 years 9 months 17 days ago

13/17 (76.47%)

$42.47 (34.95%)




2 years 9 months 18 days ago

2/2 (100%)

$40.4 (37.02%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Geoff Meacham is most bullish on?

Potential upside of $51.71 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Geoff Meacham is most reserved on?

Potential downside of -$4.54 has been obtained for ICPT (INTERCEPT PHARMACEUTICALS)

What Year was the first public recommendation made by Geoff Meacham?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart